Exosome-associated mitochondrial DNA from patients with myalgic encephalomyelitis/chronic fatigue syndrome stimulates human microglia to release IL-1β.
Irene TsilioniBenjamin NatelsonTheoharis C TheoharidesPublished in: The European journal of neuroscience (2022)
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease that presents with fatigue, sleep disturbances, malaise, and cognitive problems. The pathogenesis of ME/CFS is presently unknown, and serum levels of potential biomarkers have been inconsistent. Here, we show that mitochondrial DNA (mtDNA) associated with serum exosomes, is increased in ME/CFS patients only after exercise. Moreover, exosomes isolated from patients with ME/CFS stimulate significant release of IL-1β from cultured human microglia. These results provide evidence that activation of microglia by serum-derived exosomes may serve as a potential novel pathogenetic factor and target for treatment of ME/CFS.
Keyphrases
- mitochondrial dna
- copy number
- endothelial cells
- sleep quality
- mesenchymal stem cells
- inflammatory response
- stem cells
- end stage renal disease
- neuropathic pain
- ejection fraction
- physical activity
- mental health
- induced pluripotent stem cells
- newly diagnosed
- chronic kidney disease
- pluripotent stem cells
- high intensity
- prognostic factors
- case report
- genome wide
- gene expression
- peritoneal dialysis
- drug induced
- bone marrow
- smoking cessation
- climate change